ApproachCell therapy

CAR-T cells

Approach Europe PMC, retrieved 14 November 2026Inferred from the records, not an official entity

Kind: Approach
Topic: Cell therapy
What it covers: T cells engineered with a chimeric antigen receptor against a surface antigen (mesothelin, CLDN18.2, CEA, others); no HLA restriction